Clinical Study

Association between Single Nucleotide Polymorphism of Vitamin D Receptor Gene FokI Polymorphism and Clinical Progress of Benign Prostatic Hyperplasia

Table 1

Anthropometric and biochemical characteristics by groups.

VariableProgress group
()
Control group
()
value

Age0.13
Volume of prostate (mL)0.035
Total PSA (ng/mL)0.22
I-PSS0.018

The decrease of PSA levels was 50 percent for the patients treated with finasteride.